Assistance Publique - Hôpitaux de Paris: Purpura, Thrombocytopenic, Idiopathic trials
The registry lists 10 Purpura, Thrombocytopenic, Idiopathic studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaRecruitingNCT05338190Phase 3
- IgIV Plus Prednisone vs High-dose Dexamethasone for ITPRecruitingNCT04968899Phase 3
- Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)Status unknownNCT03975361Not applicable
- Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune CytopeniaWithdrawnNCT03965624Phase 2
- Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune ThrombocytopeniaCompletedNCT03154385Not applicable
- Immune Thrombocytopenia in PregnancyStatus unknownNCT02892630
- Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune ThrombocytopeniaStatus unknownNCT02627417Phase 3
- Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)CompletedNCT02287649Not applicable
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a SplenectomyTerminatedNCT00225875Phase 2